Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.60    0.00 (0.00%)
Bid:
10.20
Ask:
11.00
Spread: 0.80 (7.843%)
Market Cap: £14.73m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Total Voting Rights

20 Mar 2026 16:17

RNS Number : 5452X
Ebiquity PLC
20 March 2026
 

20 March 2026

 

Ebiquity Plc

("the Company" or "Ebiquity")

 

Total Voting Rights

 

The Company notifies that, following the proposed cancellation of 40,749 ordinary shares of 25p ("Ordinary Shares"), its ordinary share capital will consist of 141,215,531 Ordinary Shares. 

 

The proposed cancellation of 40,749 Ordinary Shares follows an amendment ("Amendment") to the terms of the sale and purchase agreement dated 29 March 2022 ("SPA") for the acquisition of the entire issued share capital of Media Management, LLC ("MML"), pursuant to which 679,158 Ordinary Shares (the "Consideration Shares") were issued to the MML Vendors in part payment of the deferred consideration, as announced on 29 July 2025. The Amendment sets a minimum price, being the nominal value of the Company's Ordinary Shares, at which the Consideration Shares may be issued.

 

Pursuant to the Amendment, the number of Consideration Shares to satisfy that portion of the deferred consideration has been re-calculated to be 638,409 Ordinary Shares. As a result, the MML Vendors will transfer back 40,749 Ordinary Shares to the Company for nil consideration and the Ordinary Shares so transferred will be cancelled.

 

The Ebiquity plc Employee Benefit Trust ("EBT") holds 2,262,845 Ordinary Shares to satisfy awards under the Company's share options plans. The trustee of the EBT has agreed not to vote the Ordinary Shares held by it such that these Ordinary Shares are treated as not carrying voting rights.

 

Therefore, following the cancellation of 40,749 Ordinary Shares, the total voting rights in the Company will be 141,215,531. This figure may be used by shareholders as the denominator for calculations to determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Capitalised terms in this announcement shall have the same meaning as in the acquisition announcement on 30 March 2022.

 

Enquiries:

 

Ebiquity plc

Dorcas Murray, Company Secretary

 +44 (0) 20 7650 9600

 

Camarco

Geoffrey Pelham-Lane/ Ben Woodford

ebiquity@camarco.co.uk

Cavendish Capital Markets

Nominated Advisor and Sole Broker

Ben Jeynes/ George Lawson - Corporate Finance

 +44 (0) 20 7220 0500

Julian Morse/ Louise Talbot/ Sunila de Silva - Sales/ ECM

 

 

 

 

About Ebiquity plc

 

Ebiquity is the independent authority in Marketing Effectiveness. Trusted by more than 75 of the top 100 global advertisers - and 500 more worldwide - we analyse over $100 billion in media spend each year. This unmatched scale gives us the deepest data and the sharpest insights in the industry, powering the impartial advice our clients act on to make the right decisions that deliver Effective and Responsible Advertising.

 

Our work is driven by over 650 media experts on the ground in 19 countries. Covering more than 80% of the world's media market, we are the most local and the most global, ensuring local relevance with global consistency.

 

With our evidence-based consultancy, clients transform their media operations, strengthen governance of their investments, and unlock significant incremental business growth.

 

On average, our clients achieve a 15% improvement in ROI and collectively generate over $1 billion in value annually through our digital governance programmes.

For further information, please visit: www.ebiquity.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRURANRNNUOUAR
Date   Source Headline
30th May 20193:20 pmRNSHolding(s) in Company
1st May 20197:00 amRNSTotal Voting Rights
30th Apr 201912:30 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSAnnual Report
18th Apr 20193:05 pmRNSIssue of Shares
12th Apr 201910:45 amRNSCorrection - Issue of Shares
9th Apr 20197:00 amRNSIssue of Shares
2nd Apr 201910:55 amRNSDirector/PDMR Shareholding
1st Apr 20194:40 pmRNSIssue of Shares
27th Mar 201912:25 pmRNSDirector/PDMR Shareholding
25th Mar 20192:30 pmRNSCorrection - Dividend payment schedule
25th Mar 20197:00 amRNSUnaudited Preliminary Results
1st Mar 20192:15 pmRNSTotal Voting Rights
22nd Feb 20193:55 pmRNSIssue of Shares
18th Feb 20197:00 amRNSHolding(s) in Company
12th Feb 20197:00 amRNSPre-close Trading Update
1st Feb 20197:00 amRNSTotal Voting Rights
23rd Jan 20194:50 pmRNSReplacement: Issue of Shares
23rd Jan 20193:25 pmRNSIssue of Shares
14th Jan 20193:35 pmRNSIssue of Shares
3rd Jan 20192:55 pmRNSIssue of Shares
2nd Jan 201911:40 amRNSCompletion of the disposal of the AdIntel division
2nd Jan 201911:40 amRNSDirectorate Change
2nd Jan 20197:00 amRNSTotal Voting Rights
14th Dec 20187:00 amRNSDirectorate Change
5th Dec 20181:45 pmRNSIssue of Shares
22nd Nov 20187:00 amRNSStatement re CMA final clearance notification
22nd Nov 20187:00 amRNSTrading Update
1st Nov 20187:00 amRNSTotal Voting Rights
24th Oct 20182:40 pmRNSIssue of Shares
23rd Oct 20182:05 pmRNSHolding(s) in Company
18th Oct 20184:06 pmRNSIssue of Shares
15th Oct 20187:00 amRNSIssue of Shares
11th Oct 20187:10 amRNSStatement re CMA Provisional Findings
10th Oct 201812:15 pmRNSDirectorate Change
4th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSTotal Voting Rights
27th Sep 20189:10 amRNSIssue of Shares
25th Sep 20187:00 amRNSDirectorate Change
25th Sep 20187:00 amRNSInterim Results
3rd Aug 20188:51 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
27th Jul 20188:59 amRNSHolding(s) in Company
27th Jul 20188:55 amRNSHolding(s) in Company
27th Jul 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jul 20187:00 amRNSInterim Trading Update
20th Jul 20185:00 pmRNSHolding(s) in Company
11th Jul 20183:05 pmRNSAward of options
6th Jul 20183:00 pmRNSIssue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.